ImmunoPrecise Antibodies Ltd.
HYFTNASDAQHealthcare·US · USD
$1.66
+0.08 (+5.06%)
Live · 2026-06-29Price
Key statistics
Valuation
Market cap73.80M USD
Enterprise value47.87M USD
Trailing P/E-1.82
Forward P/E-8.90
PEG ratio0.02
Price / sales2.71
Price / book7.26
Profitability
Gross margin59.26%
Operating margin-88.36%
Profit margin-43.60%
Return on assets-18.94%
Return on equity-58.82%
Income (TTM)
Revenue19.79M USD
Gross profit11.32M USD
EBITDA-7.39M USD
Net income-8.29M USD
Diluted EPS-$0.10
Rev. growth (YoY)52.40%
Balance sheet
Total cash9.92M USD
Total debt2.48M USD
Debt / equity23.72
Current ratio3.74
Book value / share$0.22
Cash flow (TTM)
Operating cash flow-7.89M USD
Levered free cash flow-2.82M USD
Shares & price
Shares outstanding46.71M
Float45.37M
Held by institutions9.68%
Beta0.82
50-day MA$1.45
200-day MA$1.61
52-week high$3.25
52-week low$0.99
Dividends
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-05-212.603.64+40.00%2026-05-074.194.70+12.17%2026-03-12-0.04-0.06−50.00%2025-12-15-0.01-0.05−400.00%2025-09-160.820.86+4.88%
About ImmunoPrecise Antibodies Ltd.
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Jennifer Lynne Bath Ph.D.
- Employees
- 81
- Headquarters
- Austin, TX, United States
- Website
- www.mindwalkai.com